Merz Pharma Group

Merz Pharmaceuticals, SAFE to launch patient-centric spasticity initiative

Tuesday, February 28, 2017

Merz Pharmaceuticals has announced the launch of Life With Spasticity, an educational online platform intended to provide comprehensive information and motivational support for stroke survivors who experience post-stroke spasticity. Designed by and for individuals living with spasticity, the project is funded by Merz and has been developed in partnership with Stroke Alliance For Europe (SAFE).

[Read More]

Merz to acquire medical device company Ulthera

Friday, June 27, 2014

Specialty healthcare company Merz will acquire Ulthera, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its ultrasound platform technology. The merger is valued at up to $600 million in upfront cash and milestone payments.

[Read More]